These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 30033000)

  • 1. Gene expression profiling identifies distinct molecular signatures in thrombotic and obstetric antiphospholipid syndrome.
    Ripoll VM; Pregnolato F; Mazza S; Bodio C; Grossi C; McDonnell T; Pericleous C; Meroni PL; Isenberg DA; Rahman A; Giles IP
    J Autoimmun; 2018 Sep; 93():114-123. PubMed ID: 30033000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of polyclonal IgG derived from patients with different clinical types of the antiphospholipid syndrome on monocyte signaling pathways.
    Lambrianides A; Carroll CJ; Pierangeli SS; Pericleous C; Branch W; Rice J; Latchman DS; Townsend P; Isenberg DA; Rahman A; Giles IP
    J Immunol; 2010 Jun; 184(12):6622-8. PubMed ID: 20483743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purified IgG from patients with obstetric but not IgG from non-obstetric antiphospholipid syndrome inhibit trophoblast invasion.
    Poulton K; Ripoll VM; Pericleous C; Meroni PL; Gerosa M; Ioannou Y; Rahman A; Giles IP
    Am J Reprod Immunol; 2015 May; 73(5):390-401. PubMed ID: 25469631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against β2 -glycoprotein i domain 1 and domain 4/5: ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndrome.
    Andreoli L; Chighizola CB; Nalli C; Gerosa M; Borghi MO; Pregnolato F; Grossi C; Zanola A; Allegri F; Norman GL; Mahler M; Meroni PL; Tincani A
    Arthritis Rheumatol; 2015 May; 67(8):2196-204. PubMed ID: 25939498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of Antiphospholipid Syndrome Atherothrombotic Risk by Unsupervised Integrated Transcriptomic Analyses.
    Pérez-Sánchez L; Patiño-Trives AM; Aguirre-Zamorano MÁ; Luque-Tévar M; Ábalos-Aguilera MC; Arias-de la Rosa I; Seguí P; Velasco-Gimena F; Barbarroja N; Escudero-Contreras A; Collantes-Estévez E; Pérez-Sánchez C; López-Pedrera C
    Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):865-877. PubMed ID: 33356391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New Biomarkers for Atherothrombosis in Antiphospholipid Syndrome: Genomics and Epigenetics Approaches.
    Lopez-Pedrera C; Barbarroja N; Patiño-Trives AM; Collantes E; Aguirre MA; Perez-Sanchez C
    Front Immunol; 2019; 10():764. PubMed ID: 31040845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Both IgG and IgM anti-beta2 glycoprotein I antibodies assays are clinically useful to the antiphospholipid syndrome diagnosis.
    Li R; Daguzan M; Vandermijnsbrugge F; Gyling M; Cantinieaux B
    Acta Clin Belg; 2014 Dec; 69(6):433-8. PubMed ID: 25103595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene profiling reveals specific molecular pathways in the pathogenesis of atherosclerosis and cardiovascular disease in antiphospholipid syndrome, systemic lupus erythematosus and antiphospholipid syndrome with lupus.
    Perez-Sanchez C; Barbarroja N; Messineo S; Ruiz-Limon P; Rodriguez-Ariza A; Jimenez-Gomez Y; Khamashta MA; Collantes-Estevez E; Cuadrado MJ; Aguirre MA; Lopez-Pedrera C
    Ann Rheum Dis; 2015 Jul; 74(7):1441-9. PubMed ID: 24618261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of purified anti-β2GPI IgG N-glycosylation associate with thrombotic, obstetric and catastrophic antiphospholipid syndrome.
    Liu T; Han J; Zhang R; Tang Z; Yi G; Gong W; Wan L; Hu Q; Teng J; Liu H; Cheng X; Ye J; Su Y; Sun Y; Shi Y; Gu J; Ren S; Yang C; Shi H
    Rheumatology (Oxford); 2022 Mar; 61(3):1243-1254. PubMed ID: 34015111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opposite Profiles of Complement in Antiphospholipid Syndrome (APS) and Systemic Lupus Erythematosus (SLE) Among Patients With Antiphospholipid Antibodies (aPL).
    Savelli SL; Roubey RAS; Kitzmiller KJ; Zhou D; Nagaraja HN; Mulvihill E; Barbar-Smiley F; Ardoin SP; Wu YL; Yu CY
    Front Immunol; 2019; 10():885. PubMed ID: 31134052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression in obstetric antiphospholipid syndrome: a systematic review.
    Muhammad Aliff M; Muhammad Shazwan S; Nur Fariha MM; Hayati AR; Nur Syahrina AR; Maizatul Azma M; Nazefah AH; Jameela S; Asral Wirda AA
    Malays J Pathol; 2016 Dec; 38(3):285-294. PubMed ID: 28028299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiphospholipid Antibodies From Women With Pregnancy Morbidity and Vascular Thrombosis Induce Endothelial Mitochondrial Dysfunction, mTOR Activation, and Autophagy.
    Rodríguez CM; Velásquez-Berrío M; Rúa C; Viana M; Abrahams VM; Cadavid AP; Alvarez AM
    Front Physiol; 2021; 12():706743. PubMed ID: 34912234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of IgG anti-Domain I beta2 Glycoprotein I antibodies by chemiluminescence immunoassay in primary antiphospholipid syndrome.
    Meneghel L; Ruffatti A; Gavasso S; Tonello M; Mattia E; Spiezia L; Tormene D; Hoxha A; Fedrigo M; Simioni P
    Clin Chim Acta; 2015 Jun; 446():201-5. PubMed ID: 25935129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factor expression in monocytes from patients with primary antiphospholipid syndrome.
    Cuadrado MJ; Buendía P; Velasco F; Aguirre MA; Barbarroja N; Torres LA; Khamashta M; López-Pedrera C
    J Thromb Haemost; 2006 Nov; 4(11):2461-9. PubMed ID: 16968331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of antiphospholipid antibodies-induced trophoblast damage by different drugs used to prevent pregnancy morbidity associated with antiphospholipid syndrome.
    Alvarez AM; Balcázar N; San Martín S; Markert UR; Cadavid AP
    Am J Reprod Immunol; 2017 Apr; 77(4):. PubMed ID: 28132398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiphospholipid antibody-induced cellular responses depend on epitope specificity : implications for treatment of antiphospholipid syndrome.
    Müller-Calleja N; Hollerbach A; Häuser F; Canisius A; Orning C; Lackner KJ
    J Thromb Haemost; 2017 Dec; 15(12):2367-2376. PubMed ID: 29024318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathophysiology of thrombosis and potential targeted therapies in antiphospholipid syndrome.
    Amengual O; Atsumi T; Koike T
    Curr Vasc Pharmacol; 2011 Sep; 9(5):606-18. PubMed ID: 21692741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiphospholipid antibodies in a large population-based cohort: genome-wide associations and effects on monocyte gene expression.
    Müller-Calleja N; Rossmann H; Müller C; Wild P; Blankenberg S; Pfeiffer N; Binder H; Beutel ME; Manukyan D; Zeller T; Lackner KJ
    Thromb Haemost; 2016 Jul; 116(1):115-23. PubMed ID: 27098658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of the adjusted global antiphospholipid syndrome score in a single centre cohort of APS patients from Turkey.
    Uludağ Ö; Bektaş M; Çene E; Sezer M; Şahinkaya Y; Gül A; Inanç M; Öcal L; Artim-Esen B
    J Thromb Thrombolysis; 2021 Feb; 51(2):466-474. PubMed ID: 32588289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insights into the diagnosis and pathogenesis of the antiphospholipid syndrome.
    Noureldine MHA; Nour-Eldine W; Khamashta MA; Uthman I
    Semin Arthritis Rheum; 2019 Apr; 48(5):860-866. PubMed ID: 30217394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.